Related references
Note: Only part of the references are listed.Synthesis and preliminary radiopharmacological characterisation of an 11C-labelled azadipeptide nitrile as potential PET tracer for imaging of cysteine cathepsins
Markus Laube et al.
JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS (2019)
Combining Nanomedicine and Immunotherapy
Yang Shi et al.
ACCOUNTS OF CHEMICAL RESEARCH (2019)
Dual-time-point 64Cu-PSMA-617-PET/CT in patients suffering from prostate cancer
Sebastian Hoberueck et al.
JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS (2019)
Tumor targeting via EPR: Strategies to enhance patient responses
Susanne K. Golombek et al.
ADVANCED DRUG DELIVERY REVIEWS (2018)
Overexpression of Receptor Tyrosine Kinase EphB4 Triggers Tumor Growth and Hypoxia in A375 Melanoma Xenografts: Insights from Multitracer Small Animal Imaging Experiments
Christin Neuber et al.
MOLECULES (2018)
Preyssler-Pope-Jeannin Polyanions [NaP5W30O110]14- and [AgP5W30O110]14-: Microwave-Assisted Synthesis, Structure, and Biological Activity
Ali Haider et al.
ZEITSCHRIFT FUR ANORGANISCHE UND ALLGEMEINE CHEMIE (2018)
Progress and challenges towards targeted delivery of cancer therapeutics
Daniel Rosenblum et al.
NATURE COMMUNICATIONS (2018)
From mono- to bivalent: improving theranostic properties of target modules for redirection of UniCAR T cells against EGFR-expressing tumor cells in vitro and in vivo
Susann Albert et al.
Oncotarget (2018)
Harnessing the Coordination Chemistry of 1,4,7-Triazacyclononane for Biomimicry and Radiopharmaceutical Applications
Tanmaya Joshi et al.
CHEMPLUSCHEM (2018)
Nonimmunogenetic Viral Capsid Carrier with Cancer Targeting Activity
Bo-Ram Lee et al.
ADVANCED SCIENCE (2018)
Imaging Nanomedicine-Based Drug Delivery: a Review of Clinical Studies
Francis Man et al.
MOLECULAR IMAGING AND BIOLOGY (2018)
Tumor heterogeneity and nanoparticle-mediated tumor targeting: the importance of delivery system personalization
K. Laxmi Swetha et al.
DRUG DELIVERY AND TRANSLATIONAL RESEARCH (2018)
Cancer nanomedicines: oversold or underappreciated?
Roy van der Meel et al.
EXPERT OPINION ON DRUG DELIVERY (2017)
Radioimmunoconjugates for treating cancer: recent advances and current opportunities
Mickael Bourgeois et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2017)
Surface charge and particle size determine the metabolic fate of dendritic polyglycerols
Kritee Pant et al.
NANOSCALE (2017)
Tumor-targeted nanomedicines for cancer theranostics
Alexandra G. Arranja et al.
PHARMACOLOGICAL RESEARCH (2017)
PET imaging of zirconium-89 labelled cetuximab: A phase I trial in patients with head and neck and lung cancer
Judith van Loon et al.
RADIOTHERAPY AND ONCOLOGY (2017)
Non-invasive assessment of murine PD-L1 levels in syngeneic tumor models by nuclear imaging with nanobody tracers
Katrijn Broos et al.
ONCOTARGET (2017)
Genetic Assembly of Double-Layered Fluorescent Protein Nanoparticles for Cancer Targeting and Imaging
Seong-Eun Kim et al.
ADVANCED SCIENCE (2017)
Nanobody-Based Delivery Systems for Diagnosis and Targeted Tumor Therapy
Yaozhong Hu et al.
FRONTIERS IN IMMUNOLOGY (2017)
Cancer nanomedicine: progress, challenges and opportunities
Jinjun Shi et al.
NATURE REVIEWS CANCER (2017)
Enhancing Tumor Penetration of Nanomedicines
Qingxue Sun et al.
BIOMACROMOLECULES (2017)
Dose-Dependent Therapeutic Distinction between Active and Passive Targeting Revealed Using Transferrin-Coated PGMA Nanoparticles
Ruhani Singh et al.
SMALL (2016)
Short- and Long-Term Tracking of Anionic Ultrasmall Nanoparticles in Kidney
Xiaowen Liang et al.
ACS NANO (2016)
Nanochemistry and Nanomedicine for Nanoparticle-based Diagnostics and Therapy
Guanying Chen et al.
CHEMICAL REVIEWS (2016)
Bispecific Antibodies for Targeted Delivery of Dendritic Polyglycerol (dPG) Prodrug Conjugates
Fatemeh Sheikhi Mehrabadi et al.
CURRENT CANCER DRUG TARGETS (2016)
Antibody-targeted nanoparticles for cancer treatment
Thomas Carter et al.
IMMUNOTHERAPY (2016)
To exploit the tumor microenvironment: Since the EPR effect fails in the clinic, what is the future of nanomedicine?
F. Danhier
JOURNAL OF CONTROLLED RELEASE (2016)
Ultrasmall inorganic nanoparticles: State-of-the-art and perspectives for biomedical applications
Kristof Zarschler et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2016)
18F-nanobody for PET imaging of HER2 overexpressing tumors
Catarina Xavier et al.
NUCLEAR MEDICINE AND BIOLOGY (2016)
Does Nanomedicine Have a Delivery Problem?
Michael Torrice
ACS CENTRAL SCIENCE (2016)
Cancer nanomedicine: is targeting our target?
Twan Lammers et al.
NATURE REVIEWS MATERIALS (2016)
Clearance Pathways and Tumor Targeting of Imaging Nanoparticles
Mengxiao Yu et al.
ACS NANO (2015)
Toward a full understanding of the EPR effect in primary and metastatic tumors as well as issues related to its heterogeneity
Hiroshi Maeda
ADVANCED DRUG DELIVERY REVIEWS (2015)
Synthesis and Biodistribution Studies of 3H- and 64Cu-Labeled Dendritic Polyglycerol and Dendritic Polyglycerol Sulfate
Kritee Pant et al.
BIOCONJUGATE CHEMISTRY (2015)
Noninvasive Imaging of Nanomedicines and Nanotheranostics: Principles, Progress, and Prospects
Sijumon Kunjachan et al.
CHEMICAL REVIEWS (2015)
Principles of nanoparticle design for overcoming biological barriers to drug delivery
Elvin Blanco et al.
NATURE BIOTECHNOLOGY (2015)
Cancer active targeting by nanoparticles: a comprehensive review of literature
Remon Bazak et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2015)
Secreted Biomolecules Alter the Biological Identity and Cellular Interactions of Nanoparticles
Alexandre Albanese et al.
ACS NANO (2014)
Cancer nanotechnology: The impact of passive and active targeting in the era of modern cancer biology
Nicolas Bertrand et al.
ADVANCED DRUG DELIVERY REVIEWS (2014)
Antibody-based imaging strategies for cancer
Jason M. Warram et al.
CANCER AND METASTASIS REVIEWS (2014)
Comparison of active, passive and magnetic targeting to tumors of multifunctional paclitaxel/SPIO-loaded nanoparticles for tumor imaging and therapy
Nathalie Schleich et al.
JOURNAL OF CONTROLLED RELEASE (2014)
Theranostic Nanoparticles
Feng Chen et al.
JOURNAL OF NUCLEAR MEDICINE (2014)
Imaging and radioimmunotherapy of multiple myeloma with anti-idiotypic Nanobodies
M. Lemaire et al.
LEUKEMIA (2014)
Passive versus Active Tumor Targeting Using RGD- and NGR-Modified Polymeric Nanomedicines
Sijumon Kunjachan et al.
NANO LETTERS (2014)
Advances in targeting strategies for nanoparticles in cancer imaging and therapy
Ji Young Yhee et al.
NANOSCALE (2014)
Diagnostic nanoparticle targeting of the EGF-receptor in complex biological conditions using single-domain antibodies
K. Zarschler et al.
NANOSCALE (2014)
Single-domain antibodies: Next-generation targeting vectors for molecular imaging
Kristof Zarschler et al.
NUCLEAR MEDICINE AND BIOLOGY (2014)
Establishment of two complementary in vitro assays for radiocopper complexes achieving reliable and comparable evaluation of in vivo stability
K. Zarschler et al.
RSC ADVANCES (2014)
Differential Roles of the Protein Corona in the Cellular Uptake of Nanoporous Polymer Particles by Monocyte and Macrophage Cell Lines
Yan Yan et al.
ACS NANO (2013)
Nanobodies: Natural Single-Domain Antibodies
Serge Muyldermans
ANNUAL REVIEW OF BIOCHEMISTRY, VOL 82 (2013)
Synthesis and Biological Evaluation of Radio and Dye Labeled Amino Functionalized Dendritic Polyglycerol Sulfates as Multivalent Anti-Inflammatory Compounds
Dominic Groeger et al.
BIOCONJUGATE CHEMISTRY (2013)
Targeted Delivery of Dendritic Polyglycerol-Doxorubicin Conjugates by scFv-SNAP Fusion Protein Suppresses EGFR+ Cancer Cell Growth
Ahmad Fawzi Hussain et al.
BIOMACROMOLECULES (2013)
Challenges and Key Considerations of the Enhanced Permeability and Retention Effect for Nanomedicine Drug Delivery in Oncology
Uma Prabhakar et al.
CANCER RESEARCH (2013)
Synthesis and radiopharmacological evaluation of 64Cu-labeled bombesin analogs featuring a bis(2-pyridylmethyl)-1,4,7triazacyclononane chelator
R. Bergmann et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2013)
Camelid single-domain antibody-fragment engineering for (pre)clinical in vivo molecular imaging applications: adjusting the bullet to its target
Jens De Vos et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2013)
Anionic Ring-Opening Polymerization Simulations for Hyperbranched Polyglycerols with Defined Molecular Weights
Florian Paulus et al.
MACROMOLECULES (2013)
High-yield production of functional soluble single-domain antibodies in the cytoplasm of Escherichia coli
Kristof Zarschler et al.
MICROBIAL CELL FACTORIES (2013)
Structural Evaluation of EGFR Inhibition Mechanisms for Nanobodies/VHH Domains
Karl R. Schmitz et al.
STRUCTURE (2013)
Discoidal Porous Silicon Particles: Fabrication and Biodistribution in Breast Cancer Bearing Mice
Biana Godin et al.
ADVANCED FUNCTIONAL MATERIALS (2012)
Assessing Nanoparticle Toxicity
Sara A. Love et al.
ANNUAL REVIEW OF ANALYTICAL CHEMISTRY, VOL 5 (2012)
Drug targeting to tumors: Principles, pitfalls and (pre-) clinical progress
Twan Lammers et al.
JOURNAL OF CONTROLLED RELEASE (2012)
Targeting of nanoparticles in cancer: drug delivery and diagnostics
Meghna Talekar et al.
ANTI-CANCER DRUGS (2011)
Radiolabeled cetuximab: dose optimization for epidermal growth factor receptor imaging in a head-and-neck squamous cell carcinoma model
Bianca A. W. Hoeben et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
A biparatopic anti-EGFR nanobody efficiently inhibits solid tumour growth
Rob C. Roovers et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Development of efficient acid cleavable multifunctional prodrugs derived from dendritic polyglycerol with a poly(ethylene glycol) shell
Marcelo Calderon et al.
JOURNAL OF CONTROLLED RELEASE (2011)
Size-Dependant Cellular Uptake of Dendritic Polyglycerol
Stephanie Reichert et al.
SMALL (2011)
Endo- and Exocytosis of Zwitterionic Quantum Dot Nanoparticles by Live HeLa Cells
Xiue Jiang et al.
ACS NANO (2010)
Time Evolution of the Nanoparticle Protein Corona
Eudald Casals et al.
ACS NANO (2010)
Dendritic Polyglycerols for Biomedical Applications
Marcelo Calderon et al.
ADVANCED MATERIALS (2010)
Structure-biocompatibility relationship of dendritic polyglycerol derivatives
Jayant Khandare et al.
BIOMATERIALS (2010)
Active targeting schemes for nanoparticle systems in cancer therapeutics
James D. Byrne et al.
ADVANCED DRUG DELIVERY REVIEWS (2008)
Synthesis, copper(II) complexation, 64Cu-labeling, and bioconjugation of a new bis(2-pyridylmethyl) derivative of 1,4,7-triazacyclononane
Gilles Gasser et al.
BIOCONJUGATE CHEMISTRY (2008)
Comparison of the biodistribution and tumor targeting of two 99mTc-labeled anti-EGFR nanobodies in mice, using pinhole SPECT/micro-CT
Lea Olive Tchouate Gainkam et al.
JOURNAL OF NUCLEAR MEDICINE (2008)
Clearance properties of nano-sized particles and molecules as imaging agents: considerations and caveats
Michelle Longmire et al.
NANOMEDICINE (2008)
Does a targeting ligand influence nanoparticle tumor localization or uptake?
Kathleen F. Pirollo et al.
TRENDS IN BIOTECHNOLOGY (2008)
Renal clearance of quantum dots
Hak Soo Choi et al.
NATURE BIOTECHNOLOGY (2007)
Efficient inhibition of EGFR signalling and of tumour growth by antagonistic anti-EGFR Nanobodies
Rob C. Roovers et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2007)
β-lactamase inhibitors derived from single-domain antibody fragments elicited in the Camelidae
KE Conrath et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2001)
Share Paper
